Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative analysis of quantitative fundus results of the left and right eyes and screening for coronary atherosclerotic disease: a binocular study.

Eye (London, England)·2026
Same author

Highland environment and genetic background are associated with myopia risk in Tibetans and Hans.

Eye (London, England)·2026
Same author

Cis-regulatory evolution reveals sensory trade-offs as a genetic basis for temporal niche evolution in tapirs.

Science advances·2026
Same author

Blue Light Defocus Induces A Positive Effect on Refractive Status and Ocular Health: A Randomized Crossover Trial.

Global challenges (Hoboken, NJ)·2025
Same author

The X-Age Project to construct a Chinese aging clock.

Nature aging·2025
Same author

A framework of biomarkers for visual system aging: a consensus statement by the Aging Biomarker Consortium.

Life medicine·2025

Related Experiment Video

Updated: Oct 15, 2025

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
09:47

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

3.8K

Retinal organoids as models for development and diseases.

Xiao Zhang1, Wen Wang1, Zi-Bing Jin2

  • 1Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Science Key Laboratory, Beijing, 100730, China.

Cell Regeneration (London, England)
|November 1, 2021
PubMed
Summary

Retinal organoids (ROs) derived from pluripotent stem cells offer promising models for studying retinal development and diseases. Further development is needed to enhance their accuracy and utility for novel therapeutic strategies.

More Related Videos

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.5K
Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells
10:05

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Published on: April 12, 2021

6.3K

Related Experiment Videos

Last Updated: Oct 15, 2025

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
09:47

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

3.8K
Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.5K
Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells
10:05

Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells

Published on: April 12, 2021

6.3K

Area of Science:

  • Stem cell biology
  • Ophthalmology
  • Regenerative medicine

Background:

  • Pluripotent stem cell-derived retinal organoids (ROs) are emerging models for retinal research.
  • These three-dimensional (3D) models offer potential for studying retinal development and disease mechanisms.
  • Current limitations include a lack of standardized quantitative analysis across differentiation protocols.

Purpose of the Study:

  • To review the current state of retinal organoid technology.
  • To discuss RO differentiation protocols and their applications in disease modeling.
  • To highlight the potential of ROs for developing novel therapeutic strategies for retinal diseases.

Main Methods:

  • Review of existing literature on retinal organoid differentiation and applications.
  • Discussion of genetic modification and patient-derived ROs for disease simulation.
  • Analysis of current quantitative technologies for RO assessment.

Main Results:

  • Retinal organoids show significant promise as preclinical models for retinal diseases.
  • Patient-derived and genetically modified ROs can mimic disease-specific microenvironments.
  • A universal quantitative analysis technology for ROs is still lacking.

Conclusions:

  • Retinal organoids are valuable tools for understanding retinal development and disease.
  • Improving differentiation efficiency, stability, and inter-model consistency is crucial.
  • Further advancements are essential for translating RO research into effective patient treatments.